Floatz logo

Genotropin

Genetic Disorder

Novo Nordisk A/Sprotein_peptidePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Genetic Disorder cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
Intergroupe Francophone du Myelome
Phase 3BB
Aoc 1044
Avidity Biosciences, Inc.
Phase 3B
DEXAMETHASONE
Quince Therapeutics S.p.A.
Phase 3B
Nexiguran Ziclumeran
Intellia Therapeutics
Phase 3B
Zeleciment Rostudirsen
Dyne Therapeutics
Phase 3B

View all 16 →

Same molecule, other indications

Genotropin is also rated in:

isolated congenital growth hormone deficiencyDormant
BBB
Indicative ·
77 / 100
View asset →
Prader-Willi syndromeDormant
BBB
Indicative ·
77 / 100
View asset →
lipodystrophyDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →